Filtros

Buscador
Año
Vílchez JA, Hernández-Romero D, Marín F. The complex role of bone turnover biomarkers in cardiovascular diseases. Eur J Heart Fail. 2013 Jun;15(6):709-10. doi: 10.1093/eurjhf/hft047. PubMed PMID: 23512094.
AÑO: 2013; IF: 6.577
Gallego P, Roldan V, Marín F, Romera M, Valdés M, Vicente V, Lip GY. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost. 2013 Dec;110(6):1189-98. doi: 10.1160/TH13-07-0556. PubMed PMID: 24096615.
AÑO: 2013; IF: 5.76
Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost. 2013 May;109(5):956-60. doi: 10.1160/TH13-01-0054. PubMed PMID: 23572113.
AÑO: 2013; IF: 5.76
Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GY. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol. 2013 Apr 15;111(8):1159-64. doi: 10.1016/j.amjcard.2012.12.045. PubMed PMID: 23337836.
AÑO: 2013; IF: 3.425
Jover E, Marín F, Roldán V, Montoro-García S, Valdés M, Lip GY. Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease. Ann Med. 2013 May;45(3):274-90. doi: 10.3109/07853890.2012.732702. Review. PubMed PMID: 23216106.
AÑO: 2013; IF: 4.733